Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133611) titled 'Randomized, Double-Blind, Multicenter Clinical Study of Songling Xuemaikang Capsules Versus Placebo in Patients With Hypertension Accompanied by Insomnia' on Sept. 29.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking University People's Hospital

Condition: Patients with mild to moderate hypertension accompanied by insomnia.

Intervention: Control group:Songling Xuemaikang Capsule Simulant (Placebo)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-30

Target Sample Size: Control group:130;Test group:130;

Countries of Recruitment: China

To ...